EZH2 and cervical cancer: Cytotoxicity of the positive control drug cisplatin and two EZH2 inhibitors was evaluated by MTT assay on two cervical cancer cell lines (HPV- C33a; HPV+ CaSki) and non-cancerous epithelial cell line following 48 h drug exposure (Figure 1).